ESPR
Esperion Therapeutics Inc.
$2.97
+$0.13(+4.58%)
50
Overall
40
Value
60
Tech
--
Quality
Market Cap
$536.32M
Volume
6.29M
52W Range
$0.69 - $3.94
Target Price
$6.09
EPS Estimates Overview
| Current Quarter | $-0.07 | Next Quarter | $-0.06 |
| Current Year | $-0.05 | Next Year | $0.07 |
| QoQ Growth | +14.3% | YoY Growth | +240.0% |
| 3Y EPS CAGR | +68.9% | Target Price | $6.09 |
| Consensus | Buy | Upside | +105.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ESPR | $2.97 | +4.6% | 6.29M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Esperion Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW